mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.2 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
7e-06 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-05 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-06 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.05 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.6 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.27 |
2e-09 |